From the Department of Anesthesiology (A.J., A.D.) the Department of Intensive Care (F.S., J.C., J.-L.V.), Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium the Department of Anesthesiology and Intensive Care, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Université Paris-Saclay, Hôpital De Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France (A.J.) the Department of Anesthesiology, University of California, San Diego, San Diego, California (B.A.) the Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, Los Angeles, California (M.C.) the Department of Anesthesiology and Perioperative Care, University of California, Irvine, Orange, California (J.R.).
Anesthesiology. 2019 Mar;130(3):394-403. doi: 10.1097/ALN.0000000000002581.
Intraoperative hypotension has been associated with adverse postoperative outcomes.A randomized controlled trial of individualized blood pressure management in patients undergoing major abdominal surgery found reduced postoperative adverse events in patients in the blood pressure management intervention group versus the standard of care group.
In this study of pigs with normovolemic hypotension induced by administration of sodium nitroprusside, an automated closed-loop vasopressor administration device was able to maintain mean arterial pressure within 5 mmHg of 80 mmHg for 98% of the intraoperative period. This suggests that norepinephrine can be accurately titrated using an automated infusion device in order to maintain target blood pressure.
Multiple studies have reported associations between intraoperative hypotension and adverse postoperative complications. One of the most common interventions in the management of hypotension is vasopressor administration. This approach requires careful and frequent vasopressor boluses and/or multiple adjustments of an infusion. The authors recently developed a closed-loop controller that titrates vasopressors to maintain mean arterial pressure (MAP) within set limits. Here, the authors assessed the feasibility and overall performance of this system in a swine model. The authors hypothesized that the closed-loop controller would be able to maintain MAP at a steady, predefined target level of 80 mmHg for greater than 85% of the time.
The authors randomized 14 healthy anesthetized pigs either to a control group or a closed-loop group. Using infusions of sodium nitroprusside at doses between 65 and 130 µg/min, we induced four normovolemic hypotensive challenges of 30 min each. In the control group, nothing was done to correct hypotension. In the closed-loop group, the system automatically titrated norepinephrine doses to achieve a predetermined MAP of 80 mmHg. The primary objective was study time spent within ±5 mmHg of the MAP target. Secondary objectives were performance error, median performance error, median absolute performance error, wobble, and divergence.
The controller maintained MAP within ±5 mmHg of the target for 98 ± 1% (mean ± SD) of the time. In the control group, the MAP was 80 ± 5 mmHg for 14.0 ± 2.8% of the time (P< 0.0001). The MAP in the closed-loop group was above the target range for 1.2 ± 1.2% and below it for 0.5 ± 0.9% of the time. Performance error, median performance error, median absolute performance error, wobble, and divergence were all optimal.
In this experimental model of induced normovolemic hypotensive episodes in pigs, the automated controller titrated norepinephrine infusion to correct hypotension and keep MAP within ±5 mmHg of target for 98% of management time.
术中低血压与术后不良结果有关。一项针对接受大型腹部手术的患者进行的个体化血压管理的随机对照试验发现,与常规护理组相比,血压管理干预组的术后不良事件减少。
在这项使用硝普钠诱导等容性低血压的猪研究中,自动闭环血管加压素给药装置能够在 98%的手术期间将平均动脉压维持在 80mmHg 以内 5mmHg。这表明可以使用自动输注装置准确滴定去甲肾上腺素以维持目标血压。
多项研究报告术中低血压与术后并发症之间存在关联。低血压管理中最常见的干预措施之一是血管加压素给药。这种方法需要仔细和频繁的血管加压素推注和/或多次调整输注。作者最近开发了一种闭环控制器,可滴定血管加压素以将平均动脉压 (MAP) 维持在设定的范围内。在这里,作者评估了该系统在猪模型中的可行性和整体性能。作者假设闭环控制器能够将 MAP 维持在稳定的、预设的 80mmHg 目标水平超过 85%的时间。
作者将 14 只健康麻醉猪随机分为对照组或闭环组。使用硝普钠输注剂量在 65 至 130µg/min 之间,我们诱导了四个 30 分钟的等容性低血压挑战。在对照组中,不采取任何措施纠正低血压。在闭环组中,系统自动滴定去甲肾上腺素剂量以达到预设的 80mmHgMAP。主要目标是研究时间内 MAP 目标的 ±5mmHg 内。次要目标是性能误差、中位性能误差、中位绝对性能误差、摆动和发散。
控制器将 MAP 维持在目标值的 ±5mmHg 范围内的时间为 98 ± 1%(平均值 ± SD)。在对照组中,MAP 为 80 ± 5mmHg,占 14.0 ± 2.8%的时间(P<0.0001)。闭环组中 MAP 在目标范围以上的时间为 1.2 ± 1.2%,以下的时间为 0.5 ± 0.9%。性能误差、中位性能误差、中位绝对性能误差、摆动和发散均为最佳。
在这项诱导猪等容性低血压发作的实验模型中,自动控制器滴定去甲肾上腺素输注以纠正低血压并使 MAP 在管理时间的 98%内保持在目标值的 ±5mmHg 内。